Christopher Fan
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Rakesh R. Ramjiawan (2 shared papers)Yunching Chen (2 shared papers)Peigen Huang (2 shared papers)Thomas Reiberger (2 shared papers)Nabeel Bardeesy (2 shared papers)Tai Hato (2 shared papers)Andrew X. Zhu (2 shared papers)Elizabeth C. Unan (1 shared paper)
- Journals
- Clinical and Experimental Gastroenterology (2 papers)The American Journal of Gastroenterology (2 papers)Nutrients (2 papers)Nature Protocols (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)
- Partner nations
- United StatesAustriaNetherlands
In The Last Decade
Christopher Fan
17 papers receiving 589 citations
Christopher Fan's Hit Papers
Peers
Comparison fields: 5 of 76
- Hepatology 124
- Immunology 209
- Oncology 254
- Cancer Research 72
- Pathology and Forensic Medicine 57
Countries citing papers authored by Christopher Fan
This map shows the geographic impact of Christopher Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fan more than expected).
Fields of papers citing papers by Christopher Fan
This network shows the impact of papers produced by Christopher Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fan. The network helps show where Christopher Fan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice Hit paper breakdown → | 2014 | 379 |
| 2 | 2015 | 88 | |
| 3 | 2022 | 32 | |
| 4 | 2013 | 16 | |
| 5 | 2015 | 15 | |
| 6 | 2019 | 11 | |
| 7 | 2013 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2015 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2019 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2024 | 0 |
About Christopher Fan
Christopher Fan is a scholar working on Surgery, Genetics, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 21 papers that have together received 596 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), Pancreatitis Pathology and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Microscopic Colitis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Nutrition and Health in Aging (2 papers), Cancer Mechanisms and Therapy (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Hepatology (124 citations), Immunology (209 citations), Oncology (254 citations), Cancer Research (72 citations) and Pathology and Forensic Medicine (57 citations). Christopher Fan has collaborated with scholars based in United States, Austria and Netherlands. Frequent co-authors include Rakesh R. Ramjiawan, Yunching Chen, Peigen Huang, Thomas Reiberger, Nabeel Bardeesy, Tai Hato, Andrew X. Zhu, Elizabeth C. Unan, Dan G. Duda and Shuji Kitahara. Their work appears in journals such as Clinical and Experimental Gastroenterology, The American Journal of Gastroenterology, Nutrients, Nature Protocols and Journal of Biomedical Materials Research Part B Applied Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.